Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.
about
The best defense is a good (Protease) offense: How Pseudomonas aeruginosa evades mucosal immunity in the lung.Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.Interleukin-22 immunotherapy during severe influenza enhances lung tissue integrity and reduces secondary bacterial systemic invasion.Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease.
P2860
Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Pseudomonas aeruginosa proteol ...... ependent lung mucosal defense.
@en
type
label
Pseudomonas aeruginosa proteol ...... ependent lung mucosal defense.
@en
prefLabel
Pseudomonas aeruginosa proteol ...... ependent lung mucosal defense.
@en
P2093
P2860
P50
P921
P1433
P1476
Pseudomonas aeruginosa proteol ...... dependent lung mucosal defense
@en
P2093
Aihua Tang
Deborah Brea
Eric Morello
Magdiel Perez-Cruz
Philippe Gosset
Reuben Ramphal
Youenn Jouan
P2860
P304
P356
10.1080/21505594.2016.1253658
P577
2016-10-28T00:00:00Z